Healthcare News and Headlines
Healthcare News and Headlines
Morpheus is an AI‑driven platform that ingests alerts from a hospital’s existing security stack—SIEM, EDR, firewalls, NDR, email security, DLP and identity tools—and stitches them into a single ransomware kill‑chain view. By correlating these signals, it can surface an attack path and recommend containment before encryption occurs, while automatically generating HIPAA breach documentation. The solution trims investigation time dramatically and provides audit‑ready evidence for OCR reviews. With healthcare breaches averaging $9.77 million and patient‑safety stakes high, Morpheus aims to turn alert overload into actionable protection.
President Trump’s "most‑favored nation" (MFN) drug pricing agreements, touted as a safeguard against excessive prescription costs, have been revealed to run for three years for several participants. SEC filings show that 16 pharmaceutical firms have entered these deals, each with...
The Centers for Medicare & Medicaid Services (CMS) is evaluating artificial‑intelligence tools to improve the precision of Medicare Advantage coding and hospital billing. The initiative is part of the Trump administration’s proposed CRUSH (Combatting and Reducing Unnecessary Spending and Healthcare...
The recent episode of HBO’s drama "The Pitt" portrayed a hospital’s IT systems being shut down by ransomware, forcing clinicians to revert to paper‑based processes. Hours later, the University of Mississippi Medical Center confirmed a real ransomware breach that crippled...
The federal government unveiled a $50 billion Rural Health Transformation Program, allocating $10 billion per year to states for preventive care, workforce development, and technology upgrades. HHS also announced stricter enforcement of information‑blocking rules, creating a portal for patient‑data complaints. Simultaneously, officials...
The American Hospital Association (AHA) submitted formal recommendations to the Assistant Secretary for Technology Policy and the Office of the National Coordinator (ASTP/ONC) regarding the Health Data, Technology and Interoperability (HTI‑5) proposed rule. The rule seeks to deregulate certification criteria,...
The American Hospital Association (AHA) unveiled the agenda for its first‑ever Healthier Together Conference, set for May 12‑14 in Dallas. The three‑day event will host more than 40 sessions delivered by nearly 200 speakers representing over 100 organizations from 20 states....
Researchers have engineered size‑shifting lipid nanoparticles that grow from ~100 nm to >300 nm after intraperitoneal injection, exploiting a capsule‑filter mechanism that blocks entry into the liver and spleen while allowing passage to the pancreas. The enlarged particles deliver mRNA payloads—including CRISPR‑Cas9...
Survival rates for congenital heart disease (CHD) have risen, creating an estimated 1.4 million adult patients who often require repeat surgeries. At the 2026 Society of Thoracic Surgeons meeting, Mayo Clinic researchers presented a machine‑learning model that isolates 15 key variables...
AI‑driven imaging firm AIRS Medical will showcase its SwiftMR™ MRI reconstruction platform at the 2026 European Congress of Radiology in Vienna. Attendees can bring anonymized DICOM data to Booth #AI-19 for real‑time reconstruction, demonstrating faster scans and sharper images. The...
Bayer's HYRNUO (sevabertinib) received accelerated FDA approval on November 19, 2025 for adult patients with HER2‑mutated, non‑squamous non‑small cell lung cancer who have progressed after prior therapy. The approval is based on the single‑arm SOHO‑01 trial, which enrolled 122 patients across 78...
ResMed has evolved from a cyclical device maker into a digital‑health platform anchored by sleep‑apnea therapy, cloud‑connected monitoring and recurring software services. The company posted Q2 FY2026 revenue of $1.4 billion, up 11% YoY, while gross margin climbed to 61.8% and...
PeerSupport.io, a Yukon health‑tech startup, launched CoWork, an autonomous AI browser that executes EMR and web‑based tasks through voice commands. In pilot clinics the tool can send referrals, renew prescriptions, and pull charts in under 11 seconds, delivering roughly 10.5...
GT Medical Technologies released Phase IV registry data showing that GammaTile brachytherapy, implanted at the time of surgical resection, achieved 92.3% local tumor control in newly diagnosed brain metastases after a median 12.4‑month follow‑up. The study of 51 patients reported a...
VahatiCor’s A‑Flux Reducer System, a self‑expanding, recapturable coronary sinus device, was implanted in a first‑in‑human cohort of 12 patients with coronary microvascular dysfunction or obstructive CAD. Eleven procedures were completed without any device‑related complications, and patients experienced significant improvements in...
UNC Health has launched the world’s first standardized rare‑disease coding tool by embedding the Mondo Disease Ontology into Epic’s EHR through the February 2026 IMO Core update. The integration adds nearly 5,000 new rare‑disease codes and revises more than 25,000...
The FDA released a draft guidance titled “Certification Process for Designated Medical Gases,” outlining how manufacturers must obtain certification and meet annual reporting requirements. The document defines qualifying products, required submission content, and FDA’s evaluation criteria. It replaces the 2015...
Evernorth, Cigna’s health‑services arm, has confirmed it now fully owns CarepathRx after completing the acquisition last year. CarepathRx provides home and ambulatory infusion solutions to roughly 10% of U.S. hospitals, strengthening Evernorth’s specialty pharmacy footprint. The deal builds on a...
The United States recorded 2,280 measles cases in 2025, the highest tally since 1991, and early 2026 has already seen 910 additional cases, concentrated in South Carolina, Utah and Florida. Low MMR vaccination coverage—just 64% for a single dose—has been...
ShopRite, part of Wakefern Food Corp., has introduced a limited‑time "Wellness Your Way" starter kit for customers beginning GLP‑1 therapy. The kit bundles medication samples, coupons and a dietitian‑crafted wellness guide, explicitly tying the chain’s pharmacy and grocery divisions. The...
Precise Bio successfully implanted PB-001, the world’s first 3D‑bioprinted, cell‑based corneal graft, in a legally blind patient during a phase‑1 trial. The implant combines human endothelial cells with a transparent collagen scaffold, replicating the properties of donor tissue. By using...
Cure Parkinson’s has expanded its Research Committee by adding eight new members from leading UK and European institutions, spanning neurology, bioinformatics, pharmacology and more. The charity also welcomed three early‑career researchers as interns, extending the programme beyond the UK to...
A randomized trial of 642 first‑time mothers showed that Baby2Home, a technology‑enabled postpartum service, significantly lowered stress, depression and anxiety scores while boosting overall health, relationship satisfaction and self‑efficacy. The digital platform combined educational content, infant‑care trackers, symptom monitoring and...
Theranica published a peer‑reviewed study confirming that its Nerivio Remote Electrical Neuromodulation (REN) wearable can be used concurrently with leading continuous glucose monitoring (CGM) systems without compromising data accuracy. The trial involved 21 adults with diabetes, testing Abbott FreeStyle Libre...
Telehealth surged from 15% to 86% of physicians between 2019 and 2021, and a 2024 survey shows 94% of patients would repeat virtual visits. This shift has turned remote care into a baseline expectation. AI is now poised to deepen...
Handl Health announced a $14.2 million Series A round led by Arthur Ventures, aimed at scaling its unified health‑plan platform for brokers, carriers, and TPAs. The solution aggregates pricing, utilization, benefit, and quality data to let employers model and continuously...
Genetic Alliance UK’s equity report warns the NHS is falling short for the 3.5 million Britons living with rare diseases. A quarter of patients wait three years for a diagnosis, only 5 % of conditions have approved treatments, and just 10 % of...
Kobe University researchers have created an AI model that diagnoses acromegaly from photographs of the back of the hand and a clenched fist, achieving higher sensitivity and specificity than seasoned endocrinologists. The system was trained on over 11,000 images contributed...
First Databank’s cloud‑native ePrescribing network, FDB Vela, has integrated with Photon Health’s digital prescription marketplace. The partnership combines FDB Vela’s HITRUST‑certified, redundant cloud infrastructure with Photon’s consumer‑focused platform that lets patients compare pharmacy options by price, location and availability before...
The American Hospital Association’s Next Generation Leaders Fellowship has launched its 2025‑2026 cohort, selecting 34 emerging health‑care leaders from across the nation. The 12‑month program pairs each fellow with an executive mentor and culminates in a capstone project aimed at...
CEREC crown technology lets Cary, NC dental offices design, mill, and place a custom ceramic crown in a single visit using digital scans and CAD/CAM software. The workflow eliminates traditional impressions, reduces chair time, and delivers a precise, aesthetic restoration....
A year-long trastuzumab emtansine (T‑DM1) regimen showed 98% three‑year invasive‑disease‑free survival in early‑stage HER2‑positive breast cancer, comparable to standard paclitaxel‑plus‑trastuzumab. The ATEMPT trial of nearly 500 patients found similar overall survival but markedly lower neuropathy and hair loss with T‑DM1,...
The FDA granted accelerated approval to Boehringer Ingelheim’s oral HER2 kinase inhibitor Hernexeos six weeks after the company filed its application, marking the second approval under the new Commissioner’s National Priority Voucher (CNPV) program. The decision expands Hernexeos use to...
A University of Otago pilot gave 26 Māori and Pacific participants e‑bikes, training and support, revealing notable improvements in mental wellbeing and management of chronic conditions such as diabetes, hypertension and asthma. Interviews conducted over 12 months showed participants valued...
Today’s brief highlights four pre‑clinical advances: Paratus Sciences unveiled PS‑1001, a pan‑inflammasome blocker targeting IL‑1β and IL‑18 for hidradenitis suppurativa; researchers identified the SCAN circuit as a core pathway disrupted in Parkinson’s disease; RX‑10616 demonstrated enhanced radiotherapy response in head‑and‑neck...
Prospect Therapeutics announced the identification of a new series of small‑molecule inhibitors targeting Janus kinase 1 (JAK1) and tyrosine kinase 2 (TYK2). The lead compounds demonstrate nanomolar potency and selectivity in biochemical assays and effectively suppress cytokine signaling in cellular...
In 1972 Wilson Greatbatch introduced lithium‑iodide batteries for implantable pacemakers, extending device life from one‑to‑two years to over a decade. This chemistry replaced unreliable mercury‑zinc cells, enabling consistent voltage output and dramatically reducing replacement surgeries. The longer power window enabled...
Employers are feeling heightened pressure from medical inflation, specialty‑drug spend and regulatory complexity, prompting a shift toward cost control as the top benefits priority, according to MetLife’s 2026 U.S. Employee Benefit Trends Study. Controlling benefit costs has become the number‑one...
The Consolidated Appropriations Act of 2026 bans pharmacy benefit managers (PBMs) from receiving compensation tied to drug list prices and mandates 100% rebate pass‑through to plan sponsors by August 2028. The law also allocates roughly $190 million to the Centers for...
Private equity firms are intensifying focus on hospice care platforms, with five notable deals reported this quarter. Kinderhook, Renovus and Revelstoke are among the investors leading the charge, targeting fragmented providers to build scalable platforms. The surge reflects broader demographic...
The FDA’s Drug Trials Snapshots program publishes concise, consumer‑focused summaries of the demographic makeup and outcomes of pivotal clinical trials for newly approved drugs. Launched in 2015, the tool covers only New Molecular Entities and original biologics approved after that...
Ionis Pharmaceuticals received FDA acceptance of its supplemental NDA for olezarsen and a priority‑review designation, with a PDUFA action date of June 30, 2026. The decision is backed by two Phase III CORE studies—CORE (n=617) and CORE2 (n=446)—that evaluated once‑monthly subcutaneous...
The American Heart Association’s new scientific statement projects that nearly six in ten U.S. women will live with cardiovascular disease (CVD) by 2050, driven by rising hypertension, obesity, and diabetes. By 2050, high blood pressure could affect almost 60% of...
GSK’s depemokimab, marketed as EXDENSUR, received FDA approval on December 16, 2025 as a six‑month subcutaneous add‑on for severe eosinophilic asthma in patients aged 12 and older. Approval was based on two 52‑week, double‑blind, placebo‑controlled trials (SWIFT‑1 and SWIFT‑2) that...
BrightSpring Health Services reported a strong fourth‑quarter and full‑year 2025, with net revenue climbing 28% to $12.9 billion and adjusted EBITDA rising 34% to $618 million. The company turned a net loss in 2024 into a $104.8 million profit for the year and...
UW Medicine and Seattle Children’s Hospital received $328,133 from the Sudden Unexplained Death in Childhood (SUDC) Foundation to launch a four‑year study using PacBio HiFi long‑read sequencing as a first‑line test. The project will sequence 200 child‑parent trios to uncover...
The FDA issued a suite of new guidance documents in early 2026 aimed at easing development of therapies for rare diseases, including the Rare Disease Evidence Pathway, Plausible Mechanism Pathway, and innovative trial designs for cellular and gene therapies. The...
Quotient Sciences has extended its commercial partnership with Ipsen to manufacture Sohonos (Palovarotene), the approved therapy for fibrodysplasia ossificans progressiva (FOP), an ultra‑rare disease affecting fewer than 1,000 people worldwide. The deal includes Ipsen's investment in a pneumatic closed‑transfer system...
ENDRA Life Sciences announced that its Taeus Liver device achieved high measurement consistency in a MASLD study, recording an intraclass correlation coefficient of 0.89 and a standard error of measurement of 3.3%. The trial involved 14 participants and 56 data...
Eli Lilly disclosed Phase III ACHIEVE‑3 results showing its oral GLP‑1 agonist orforglipron outperformed oral semaglutide in lowering A1C and inducing weight loss. The 52‑week, open‑label trial enrolled 1,698 patients across six countries and compared two doses of each drug. Orforglipron also...
